Torrent Pharmaceuticals 미래 성장
Future 기준 확인 5/6
Torrent Pharmaceuticals (는) 각각 연간 22.7% 및 12.1% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 22.7% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 29.8% 로 예상됩니다.
주요 정보
22.7%
수익 성장률
22.7%
EPS 성장률
| Pharmaceuticals 수익 성장 | 17.9% |
| 매출 성장률 | 12.1% |
| 향후 자기자본 수익률 | 29.8% |
| 애널리스트 커버리지 | Good |
| 마지막 업데이트 | 02 Nov 2024 |
최근 미래 성장 업데이트
Earnings Miss: Torrent Pharmaceuticals Limited Missed EPS By 7.7% And Analysts Are Revising Their Forecasts
Oct 29
Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Just Reported And Analysts Have Been Lifting Their Price Targets
Jul 26Recent updates
Earnings Miss: Torrent Pharmaceuticals Limited Missed EPS By 7.7% And Analysts Are Revising Their Forecasts
Oct 29Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Popularity With Investors Is Under Threat From Overpricing
Oct 24Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Just Reported And Analysts Have Been Lifting Their Price Targets
Jul 26Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) P/E Is On The Mark
Apr 16Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?
Mar 03Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹22.00
Feb 05Investors Interested In Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Earnings
Jan 07Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Rather Sparingly
Nov 14Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Jun 01Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Mar 01Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Jul 25Torrent Pharmaceuticals' (NSE:TORNTPHARM) Soft Earnings Don't Show The Whole Picture
Jun 02Estimating The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
May 25A Look At The Intrinsic Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
Feb 18Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹25.00
Jan 27Here's Why Torrent Pharmaceuticals (NSE:TORNTPHARM) Can Manage Its Debt Responsibly
Jan 04Here's Why I Think Torrent Pharmaceuticals (NSE:TORNTPHARM) Is An Interesting Stock
Dec 14A Look At The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
Nov 07Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Sep 30Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Deserve A Spot On Your Watchlist?
Sep 01Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Jul 02I Ran A Stock Scan For Earnings Growth And Torrent Pharmaceuticals (NSE:TORNTPHARM) Passed With Ease
Jun 01Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Shares Could Be 30% Above Their Intrinsic Value Estimate
May 14Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?
Mar 23수익 및 매출 성장 예측
| 날짜 | 수익 | 수익 | 잉여 현금 흐름 | 작전 현금 | 평균 애널리스트 수 |
|---|---|---|---|---|---|
| 3/31/2027 | 151,563 | 31,291 | 34,410 | 37,370 | 24 |
| 3/31/2026 | 135,063 | 26,155 | 30,192 | 33,411 | 30 |
| 3/31/2025 | 119,548 | 20,165 | 23,530 | 26,996 | 30 |
| 9/30/2024 | 112,238 | 18,024 | 29,293 | 34,091 | N/A |
| 6/30/2024 | 109,958 | 17,354 | N/A | N/A | N/A |
| 3/31/2024 | 107,278 | 16,564 | 28,333 | 32,661 | N/A |
| 12/31/2023 | 104,742 | 14,942 | N/A | N/A | N/A |
| 9/30/2023 | 102,332 | 13,432 | 24,212 | 28,691 | N/A |
| 6/30/2023 | 98,642 | 12,692 | N/A | N/A | N/A |
| 3/31/2023 | 96,202 | 12,452 | 17,942 | 23,681 | N/A |
| 12/31/2022 | 92,580 | 8,312 | N/A | N/A | N/A |
| 9/30/2022 | 88,750 | 7,972 | 15,574 | 19,380 | N/A |
| 6/30/2022 | 87,210 | 8,012 | N/A | N/A | N/A |
| 3/31/2022 | 85,080 | 7,772 | 16,004 | 18,030 | N/A |
| 12/31/2021 | 83,158 | 12,189 | N/A | N/A | N/A |
| 9/30/2021 | 82,028 | 12,669 | 15,015 | 17,827 | N/A |
| 6/30/2021 | 80,828 | 12,609 | N/A | N/A | N/A |
| 3/31/2021 | 80,046 | 12,519 | 16,702 | 20,054 | N/A |
| 12/31/2020 | 80,143 | 12,417 | N/A | N/A | N/A |
| 9/30/2020 | 79,853 | 11,957 | 13,690 | 18,078 | N/A |
| 6/30/2020 | 79,733 | 11,297 | N/A | N/A | N/A |
| 3/31/2020 | 79,393 | 10,247 | 9,861 | 13,929 | N/A |
| 12/31/2019 | 78,488 | 5,593 | N/A | N/A | N/A |
| 9/30/2019 | 79,338 | 5,543 | 10,463 | 16,981 | N/A |
| 6/30/2019 | 78,228 | 4,893 | N/A | N/A | N/A |
| 3/31/2019 | 76,728 | 4,363 | 11,353 | 17,981 | N/A |
| 12/31/2018 | 75,141 | 8,161 | N/A | N/A | N/A |
| 9/30/2018 | 69,891 | 6,281 | N/A | N/A | N/A |
| 6/30/2018 | 65,121 | 6,531 | N/A | N/A | N/A |
| 3/31/2018 | 59,498 | 6,781 | N/A | 8,942 | N/A |
| 12/31/2017 | 56,727 | 6,556 | N/A | N/A | N/A |
| 9/30/2017 | 56,387 | 8,266 | N/A | N/A | N/A |
| 6/30/2017 | 56,387 | 8,296 | N/A | N/A | N/A |
| 3/31/2017 | 58,157 | 9,336 | N/A | 10,088 | N/A |
| 12/31/2016 | 59,154 | 10,014 | N/A | N/A | N/A |
| 9/30/2016 | 60,144 | 10,624 | N/A | N/A | N/A |
| 6/30/2016 | 62,744 | 13,644 | N/A | N/A | N/A |
| 3/31/2016 | 66,669 | 17,332 | N/A | 27,421 | N/A |
| 12/31/2015 | 63,315 | 16,299 | N/A | N/A | N/A |
| 9/30/2015 | 59,605 | 13,139 | N/A | N/A | N/A |
| 6/30/2015 | 54,865 | 9,439 | N/A | N/A | N/A |
| 3/31/2015 | 46,535 | 7,509 | N/A | 8,102 | N/A |
| 12/31/2014 | 47,247 | 8,649 | N/A | N/A | N/A |
| 9/30/2014 | 45,717 | 8,559 | N/A | N/A | N/A |
| 6/30/2014 | 43,267 | 7,709 | N/A | N/A | N/A |
| 3/31/2014 | 41,847 | 6,639 | N/A | 5,994 | N/A |
| 12/31/2013 | 38,291 | 5,308 | N/A | N/A | N/A |
애널리스트 미래 성장 예측
수입 대 저축률: TORNTPHARM 의 연간 예상 수익 증가율( 22.7% )이 saving rate( 6.7% 보다 높습니다. ).
수익 vs 시장: TORNTPHARM 의 연간 수익( 22.7% ) Indian 시장( 17.9% 보다 빠르게 성장할 것으로 예상됩니다. 17.9% 연간).
고성장 수익: TORNTPHARM 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.
수익 대 시장: TORNTPHARM 의 수익(연간 12.1% ) Indian 시장( 10.5% 보다 빠르게 성장할 것으로 예상됩니다. 10.5% 연간).
고성장 수익: TORNTPHARM 의 수익(연간 12.1% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.
주당 순이익 성장 예측
미래 자기자본 수익률
미래 ROE: TORNTPHARM 의 자본 수익률은 3년 내에 최고 수준이 될 것으로 예상됩니다. ( 29.8 %)